| Mrs Shanon Pleshette Snead, CRNP | |
|
1501 W Mount Royal Ave, Baltimore, MD 21217-4289 | |
| (410) 225-1325 | |
| Not Available |
| Full Name | Mrs Shanon Pleshette Snead |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 1501 W Mount Royal Ave, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235416835 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SF0001X | Clinical Nurse Specialist - Family Health | R157353 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Shanon Pleshette Snead, CRNP 2015 Spring Rd, Ste 300, Oak Brook, IL 60523-3944 Ph: (630) 725-2700 | Mrs Shanon Pleshette Snead, CRNP 1501 W Mount Royal Ave, Baltimore, MD 21217-4289 Ph: (410) 225-1325 |
News Archive
In a large-scale, international study led by renowned rheumatologist Josef Smolen from the Department of Medicine III, a still-to-be-approved drug containing the selective janus kinase inhibitor upadacitinib has proved itself to be a new option for treating active rheumatoid arthritis.
A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has developed a predictive computer model that, when tested on real pandemic data, proposed strategies that would have reduced the rate of both COVID-19 infections and deaths by an average of 72 percent, based on a sample from four countries.
Hearing aids for as many as ten million Americans living with untreated hearing loss could soon become a reality if Congress acts, according to Stephen Hansbrough, CEO of HearUSA (Amex: EAR), one of the nation's largest hearing care companies.
Health Canada has released a consultation document,"Building On Success - A Proposal for New Health-Related Information on Tobacco Product Labels," outlining proposed changes to the current labelling requirements for tobacco product packaging.
On the 13th of September 2017, a U.S. Food and Drug Administration (FDA) advisory panel has voted 11 to 0 approving a shingles vaccine for its use in adults aged 50 and over. The panel unanimously accepted the safety and efficacy of the vaccine and thus GlaxoSmithKline's Shingrix is on its way to FDA approval.
› Verified 6 days ago
Brooke Adams Vacovsky, MSN, RN, AGCNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2401 W Belvedere Ave, Baltimore, MD 21215 Phone: 410-601-8133 | |
Jennifer Helzer, APRN-CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-350-7234 | |
Stephanie Morgenstern, APRN, ACCNS-P Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1800 Orleans St, Baltimore, MD 21287 Phone: 339-235-0624 | |
Megan Wanzer, DNP, CRNP, CNS, CCRN Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-5382 | |
Mr. Timothy Henrique Anthony Madeira, CRNP, APRN-CNS Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-5080 | |
Elizabeth K Zink, MS, RN, CCNS, CNRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1800 Orleans St Rm 3074, Baltimore, MD 21287 Phone: 410-955-5253 | |
Kenneth G Muthee, Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1340 Smith Ave Ste 200, Baltimore, MD 21209 Phone: 443-500-9251 Fax: 410-779-1314 |